Clinical heterogeneity in newly diagnosed Parkinson’s disease

摘要

To determine clinical heterogeneity in newly diagnosed Parkinson’s disease using cluster analysis and to describe the subgroups in terms of impairment, disability, perceived quality of life, and use of dopaminergic therapy.